BiVictriX Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has BiVictriX Therapeutics's balance sheet done over the years? Its assets were worth $4,295,000 last year, which is less than in the previous period. 18% of BiVictriX Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $758,000, which means an increase by 31% compared compared to last year.

Debt to Assets

BiVictriX Therapeutics Plc (LSE:BVX.L): Debt to assets
2018 348000 38K 10.92%
2019 266000 86K 32.33%
2020 7736000 330K 4.27%
2021 6881000 554K 8.05%
2022 4536000 579K 12.76%
2023 4295000 758K 17.65%

BVX.L Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
3.27M3.28M6.06M7.53M129K211K
Short term investments
000000
Net receivables
0565K260K136K00
Inventory
000000
Other current assets
540K113K219K6.99K0136K
Total current assets
3.81M3.96M6.54M7.67M265K347K
Non-current assets:
Property, Plant and Equipment
476K571K339K63K1K1K
Goodwill
000000
Intangible assets
000000
Long term investments
000000
Other non-current assets
000000
Total non-current assets
476K571K339K63K1K1K
Total assets
4.29M4.53M6.88M7.73M266K348K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
-209K00000
Short term debt
128K107K71K000
Total current liabilities
624K391K379K330K86K38K
Non-current liabilities:
Long term debt
134K188K175K671K00
Deferred tax
000000
Other non-current liabilities
000-100
Total non-current liabilities
134K188K175K670.99K00
Total liabilities
758K579K554K330K86K38K
Data sourceData sourceData sourceData sourceData sourceData source